United States FemTech Market
U.S. FemTech Market by Type (Devices, Software, and Services), Application (Reproductive Health, Pregnancy & Nursing Care, Pelvic & Uterine Healthcare, and General Healthcare & Awareness), and End-User (Hospital, Fertility Clinics, Diagnostic Centers, and Others), is expected to grow at a steady CAGR forecast till 2032 owing to the rising adoption of digital health solutions in us, advancements in artificial intelligence and virtual assistance, and growing availability of smart wearable devices in the U.S.
The United States femtech market was valued at USD 2.59 billion in 2024, growing at a CAGR of 15.98% during the forecast period from 2025 to 2032 to reach USD 8.33 billion by 2032. The rising adoption of digital health solutions in the U.S. is significantly boosting the FemTech market by enabling personalized and accessible healthcare for women through mobile apps, telemedicine, and remote monitoring. Advancements in artificial intelligence (AI) and virtual assistance further enhance the market by providing sophisticated tools for early diagnosis, predictive analytics, and tailored health recommendations for conditions such as reproductive health, pregnancy, and menopause. Additionally, the growing availability of smart wearable devices, such as fitness trackers and fertility monitors, empowers women to actively manage their health and wellness, driving demand for FemTech solutions. Together, these factors are fostering innovation, improving healthcare outcomes, and expanding the reach of FemTech products, propelling the market's growth in the U.S., during the forecast period from 2025 to 2032.
U.S. FemTech Market Dynamics:
The femtech market is experiencing growth due to several contributing factors, with one of the primary drivers being the rising demand for digital Technology. For instance, women are increasingly using mobile apps and wearable devices to track their menstrual cycles, monitor pregnancies, and manage reproductive health.
Digital technologies such as mobile apps, wearable devices, and online health platforms provide convenient and effective ways to monitor various aspects of health, including menstrual cycles, fertility, pregnancy, and menopause. This awareness is driving more women to seek out digital health solutions thereby boosting the market of femtech.
The growing interest in femtech has attracted significant investment from venture capitalists, healthcare companies, and technology firms. This influx of funding has spurred innovation, leading to the development of new products and services that address a wide range of women's health issues. Among the many prominent drivers for the femtech market in the U.S., the growing availability of smart wearable technologies for women in the healthcare sector is also a major driver for the U.S. femtech market.
Applications for wearable technology may be able to alleviate some of the present obstacles that women encounter when trying to get access to high-quality healthcare. By giving women the ability to make educated decisions, obtain the necessary healthcare services, take charge of their bodies, and overcome some of the current inequalities, this technology will contribute to women's health empowerment. These wearables can track several menstrual cycle parameters, like the duration of the follicular and luteal phases, and anticipate ovulation, which helps with family planning.
One of the best and most widely used wearable in this category is the Oura Ring, which is also a menstrual cycle monitor in addition to being a sleep fitness tracker. It makes monthly predictions about the start of the menstrual cycle based on data gathered on body temperature. Smartwatch users of Fitbit and Garmin too, have the option to record information about their menstrual cycles, which might provide them with insights about their cycle.
Wearables for women in the healthcare sector are also revolutionizing the segments of fertility tracking, pregnancy monitoring, and breast health, among others. For example, the Ava bracelet helps women in the monitoring of their fertility. Therefore, to precisely determine a woman's reproductive window, the system gathers and evaluates a wide range of data, such as skin temperature at night, heat rate variability ratio, resting pulse rate, and more. The continuous innovation in the femtech space keeps the market dynamic and expanding. For instance, in July 2021, the U.S. FDA approved and gave clearance to Natural Cycles to use body temperature data readings collected by smart wearables, such as the Oura smart ring, for assessing a woman’s fertility and managing pregnancy. Thus, the rising adoption of digital health solutions will eventually help to propel the demand of the femtech market during the forecast period. Thus, the factors mentioned above are expected to boost the overall market of U.S. FemTech during the forecast period from 2025 to 2032.
However, cybersecurity and privacy concerns and a lack of proper regulations and user studies in the femtech market may hinder the future market of U.S. FemTech during the forecasted period.
U.S. FemTech Market Segment Analysis:
U.S. FemTech Market by Type (Devices, Software, and Services), Application (Reproductive Health, Pregnancy & Nursing Care, Pelvic & Uterine Healthcare, and General Healthcare & Awareness), and End-User (Hospital, Fertility Clinics, Diagnostic Centers, and Others)
The devices category in the U.S. femtech market is estimated to dominate the market with a market share of 59.33% in 2024. The wide range of tools and products that are used for women's health improvement, consisting of wearable devices, treatment devices, and others are considered femtech devices. The demand for femtech devices is expected to grow during the forecast period owing to growing female awareness of personal health and hygiene, rising infectious diseases among women, and significant investments made by the government and other organizations in the products’ development segment, among others.
FemTech devices are revolutionizing women’s healthcare segment by empowering them to manage their health, offering tailored solutions, raising awareness, and lowering barriers to care access. Several different types of wearable devices are available in the market that cater to specific needs related to sexual, maternal, and menstrual health. For example, a breast pump that helps extract milk from a breastfeeding woman's breasts. Breast pumps can either be manual (a hand pump) or electric.
Moreover, the demand for managing conditions such as osteoporosis and cardiovascular disease is also growing. FemTech devices hold immense potential to advance overall well-being throughout their lifetime, reduce healthcare inequities, and enhance health outcomes for women.
Well-established brands as well as new startups are continuously involved in the development and launch of innovative and advanced FemTech devices. For example, in September 2024, Femto Technologies Inc., formerly known as BYND Cannasoft Enterprises Inc., a leading innovator in the FemTech industry, with FDA-Registered Manufacturer announced the launch of flagship AI-driven femtech product pods in the U.S. These femtech devices can help women whose health needs are neglected, dismissed, or ignored to a greater degree than men. Additionally, femtech firms offer portable devices and home diagnostics that greatly enhance women's general health and quality of life by making healthcare services easily accessible and encouraging self-care. Thus, women can take better charge of their health and health-related data femtech devices thereby boosting the overall market in the U.S.
Thus, the factors mentioned above are expected to boost the segment thereby boosting the overall market of U.S. FemTech.
U.S. FemTech Market Key Players:
Some of the key market players operating in the U.S. FemTech market include HeraMED, Sera Prognostics, Flo Health Inc., iSono Health, Inc., Nuvo Inc., Natural Cycles, Canopie, Tempdrop, Glow Inc., Clue by Biowink GmbH, Oura Health Oy., Garmin, Mira, Kimberly-Clark Corporation, Joylux, Inc., March Inc., Allara Health, Thirty Madison, Kindbody, Unified Women’s Healthcare, and others.
Recent Developmental Activities in the U.S. FemTech Market:
- In November 2023, Movano Health announced the launch of the Evie Ring, a new smart ring offering health and fitness monitoring features specifically tailored for women.
- In November 2023, ŌURA, a smart ring technology firm, and Clue, a period monitoring and reproductive health app, collaborated to improve female health research and personal health management by integrating ŌURA's biometric sensing capabilities with Clue's menstrual health tracking.
- In November 2022, Maven Clinic, a teletherapy firm with a focus on women's health, raised U.S.D 90 BILLION in Series E fundraising which is the year's largest Femtech deal. Maven also had reportedly raised more than U.S.D 300 BILLION in total capital.
Key Takeaways from the U.S. FemTech Market Report Study
- Market size analysis for current U.S. femtech size (2024), and market forecast for 8 years (2025 to 2032)
- Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
- Key companies dominating the U.S. femtech market.
- Various opportunities available for the other competitors in the U.S. femtech market space.
- What are the top-performing segments in 2024? How these segments will perform in 2032?
- Which are the top-performing regions and countries in the current U.S. FemTech market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for U.S. FemTech market growth in the coming future?
Target Audience Who Can be benefited from this U.S. FemTech Market Report Study
- U.S. femtech product providers
- Research organizations and consulting companies
- U.S. femtech-related organizations, associations, forums, and other alliances
- Government and corporate offices
- Start-up companies, venture capitalists, and private equity firms
- Distributors and traders dealing in U.S. femtech
- Various end-users who want to know more about the U.S. femtech market and the latest technological developments in the U.S. femtech market.
Frequently Asked Questions for the U.S. FemTech Market:
1. What is femtech?
- Femtech is a phrase used to describe software and services that use technology specifically designed for women's health. This covers fertility treatments, period-tracking applications, prenatal and nursing care, sexual wellness for women, and reproductive system health.
2. What is the market for U.S. femtech?
- The United States femtech market was valued at USD 2.59 billion in 2024, growing at a CAGR of 15.98% during the forecast period from 2025 to 2032 to reach USD 8.33 billion by 2032.
3. What are the drivers for the U.S. femtech market?
- The rising adoption of digital health solutions in the U.S. is significantly boosting the FemTech market by enabling personalized and accessible healthcare for women through mobile apps, telemedicine, and remote monitoring. Advancements in artificial intelligence (AI) and virtual assistance further enhance the market by providing sophisticated tools for early diagnosis, predictive analytics, and tailored health recommendations for conditions such as reproductive health, pregnancy, and menopause. Additionally, the growing availability of smart wearable devices, such as fitness trackers and fertility monitors, empowers women to actively manage their health and wellness, driving demand for FemTech solutions. Together, these factors are fostering innovation, improving healthcare outcomes, and expanding the reach of FemTech products, propelling the market's growth in the U.S., during the forecast period from 2025 to 2032.
4. Who are the key players operating in the U.S. femtech market?
- Some of the key market players operating in the U.S. femtech are HeraMED, Sera Prognostics, Flo Health Inc., iSono Health, Inc., Nuvo Inc., Natural Cycles, Canopie, Tempdrop, Glow Inc., Clue by Biowink GmbH, Oura Health Oy., Garmin, Mira, Kimberly-Clark Corporation, Joylux, Inc., March Inc., Allara Health, Thirty Madison, Kindbody, Unified Women’s Healthcare, and others.

